About
SATMEG Ventures commercialises research from the Sahlgrenska Translational Melanoma Group to develop personalised therapies for melanoma and other solid tumours.
Explore SATMEG Ventures's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.